Joint associations of serum phosphate and the hemoglobin glycation index with postoperative sepsis and mortality after cardiac surgery: a retrospective cohort study

When the heart is stopped and restarted during surgery, the body undergoes a profound shock. It is a moment where the delicate balance of internal chemistry is tested by trauma, the temporary use of a heart-lung machine, and the stress of healing. In the days that follow, the immune system must fight a battle on two fronts: repairing the physical damage while fending off potential infections. Sometimes, this defense system goes into overdrive, leading to sepsis, a life-threatening reaction that can cause organ failure. For decades, doctors have relied on standard blood tests to gauge a patient's health, looking at sugar levels and kidney function. However, two specific markers have recently come under scrutiny for what they might reveal about a patient's hidden vulnerability: a measure of how the body handles sugar over time, and the level of phosphate, a mineral essential for energy, in the blood. Understanding these markers could help predict who is most likely to develop a severe infection after heart surgery and who might struggle to survive the long road to recovery.

A team of researchers at XinHua Hospital in Shanghai set out to investigate these two markers using a massive, anonymized database of critical care records from the United States. They focused on nearly 2,700 adults who had undergone major heart surgery, such as bypass operations or valve replacements, and were admitted to the intensive care unit. The scientists looked for two specific things: whether the patient developed sepsis while in the hospital, and if they did, whether they survived for the next year. To do this, they examined the patients' blood work taken within the first day of their ICU stay. They calculated a specific score called the hemoglobin glycation index, which measures the difference between a patient's actual long-term sugar levels and what those levels should be based on their current blood sugar. They also checked the concentration of phosphate in the blood, categorizing it as normal, too low, or too high.

The study revealed a clear, though complex, pattern. Patients with a higher hemoglobin glycation index were more likely to develop sepsis after their surgery. This suggests that a body that has been under metabolic stress for a long time, even if sugar levels appear controlled, may be less equipped to handle the sudden inflammatory shock of surgery. Similarly, patients with high levels of phosphate in their blood were also more likely to develop an infection. When the researchers looked at the combination of these factors, the risk was highest for patients who had both a high glycation index and abnormal phosphate levels. However, the ability of these two numbers alone to predict who would get sick was limited; they were useful clues, but not a crystal ball.

The story changed once the patients actually developed sepsis. Among the 504 patients who fell ill, the researchers tracked their survival over 360 days. Here, the findings took an unexpected turn. Patients with lower hemoglobin glycation index scores were more likely to die within that year, while those with higher scores had better survival rates. This seems to contradict the earlier finding that high scores predicted getting sick in the first place. The researchers suggest this is because the two outcomes rely on different biological mechanisms. A high score might indicate a body primed for inflammation, making it susceptible to infection. But once the infection is established, a very low score might signal that the patient is frail, malnourished, or suffering from severe anemia, leaving them without the reserves needed to survive the long haul.

Phosphate levels told a different story regarding long-term survival. For patients who had developed sepsis, having phosphate levels that were either too low or too high was a sign of danger. Those with normal phosphate levels fared significantly better. The data showed a U-shaped risk curve, where both extremes of phosphate imbalance were linked to higher mortality rates. When the researchers combined the two markers, they found that patients with low glycation scores and abnormal phosphate levels faced the highest risk of death within a year. Adding these two blood markers to standard clinical data improved the ability to predict long-term survival, raising the accuracy of the prediction model from a moderate level to a much stronger one.

Despite these promising associations, the authors are careful not to declare these markers as definitive tools for decision-making. The study was retrospective, meaning it looked back at existing data rather than testing a new treatment, which means it can show links but cannot prove that one thing causes the other. The number of deaths in the group that developed sepsis was relatively small, which makes the statistical results less certain. Furthermore, the study did not include an external group of patients to verify the findings. The researchers conclude that while the hemoglobin glycation index and serum phosphate offer valuable, complementary insights into a patient's metabolic state, they should be viewed as part of a broader clinical picture rather than standalone predictors. These findings suggest that the body's long-term sugar history and its immediate mineral balance tell different parts of the same story about survival, offering a more nuanced view of who is truly vulnerable after the trauma of heart surgery.